Stock Analysis on Net
Stock Analysis on Net

AmerisourceBergen Corp. (NYSE:ABC)

This company has been moved to the archive! The financial data has not been updated since August 2, 2023.

Analysis of Long-term (Investment) Activity Ratios

Microsoft Excel

Long-term Activity Ratios (Summary)

AmerisourceBergen Corp., long-term (investment) activity ratios

Microsoft Excel
Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Net fixed asset turnover 111.75 98.93 127.89 101.43 88.74 85.18
Net fixed asset turnover (including operating lease, right-of-use asset) 77.46 66.25 98.48 101.43 88.74 85.18
Total asset turnover 4.22 3.73 4.29 4.58 4.46 4.34
Equity turnover — 958.07 — 62.38 57.26 74.18

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).


The analysis of investment activity ratios reveals a company with a highly asset-light operating model, characterized by exceptionally high fixed asset turnover and relative stability in total asset utilization, despite significant volatility in equity-related metrics.

Net Fixed Asset Turnover
A general upward trend in net fixed asset turnover is observed from 2017 to 2020, rising from 85.18 to a peak of 127.89. This indicates increasing efficiency in generating revenue per unit of net fixed assets. While a contraction occurred in 2021 to 98.93, the ratio recovered to 111.75 by 2022, maintaining a high baseline that suggests minimal reliance on heavy capital investment to drive sales.
Impact of Right-of-Use Assets
The inclusion of operating lease right-of-use assets creates a divergent trend starting in 2020. While the standard net fixed asset turnover peaked in 2020, the lease-adjusted ratio began a decline, dropping from 98.48 in 2020 to 66.25 in 2021, before a partial recovery to 77.46 in 2022. The widening gap between these two metrics suggests a substantial increase in leased assets relative to owned fixed assets during this period.
Total Asset Turnover
Total asset turnover remained relatively stable between 2017 and 2022, fluctuating within a narrow range between 3.73 and 4.58. A peak in efficiency was noted in 2019 at 4.58, followed by a dip to 3.73 in 2021. The return to 4.22 in 2022 indicates a normalization of the relationship between total assets and revenue generation.
Equity Turnover
Equity turnover exhibits extreme volatility and incomplete reporting. After fluctuating between 57.26 and 74.18 from 2017 to 2019, a significant anomaly is observed in 2021, where the ratio surged to 958.07. Such a sharp increase typically indicates a dramatic reduction in the equity base relative to revenue, potentially resulting from aggressive share repurchases or other capital restructuring activities.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Net Fixed Asset Turnover

AmerisourceBergen Corp., net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Selected Financial Data (US$ in thousands)
Revenue 238,587,006 213,988,843 189,893,926 179,589,121 167,939,635 153,143,826
Property and equipment, net 2,135,003 2,162,961 1,484,808 1,770,516 1,892,424 1,797,945
Long-term Activity Ratio
Net fixed asset turnover1 111.75 98.93 127.89 101.43 88.74 85.18
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories 4.76 4.81 — — — —
Elevance Health Inc. 36.07 34.94 — — — —
Intuitive Surgical Inc. 2.62 3.04 — — — —
Medtronic PLC 5.85 5.77 — — — —
UnitedHealth Group Inc. 31.81 31.81 — — — —
Net Fixed Asset Turnover, Sector
Health Care Equipment & Services 17.82 17.31 — — — —
Net Fixed Asset Turnover, Industry
Health Care 7.88 7.74 — — — —

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

1 2022 Calculation
Net fixed asset turnover = Revenue ÷ Property and equipment, net
= 238,587,006 ÷ 2,135,003 = 111.75

2 Click competitor name to see calculations.


A consistent upward trajectory in revenue is observed from 2017 through 2022, with figures increasing from approximately 153.1 billion US$ to 238.6 billion US$. This growth occurs alongside fluctuations in net property and equipment, leading to a volatile but generally positive trend in the net fixed asset turnover ratio.

Revenue Growth and Asset Efficiency
Revenue expanded steadily over the six-year period, while net property and equipment remained relatively stable, fluctuating between 1.48 billion US$ and 2.16 billion US$. This disparity indicates that the company generates substantial sales volume relative to its investment in fixed assets, characterized by a high turnover ratio throughout the analyzed period.
Peak Efficiency in 2020
The net fixed asset turnover ratio reached its peak of 127.89 in 2020. This surge was driven by a combination of increasing revenue and a simultaneous reduction in net property and equipment to its lowest point of 1.48 billion US$, indicating maximum utilization of the existing fixed asset base.
Capital Investment Impact in 2021
A significant contraction in the turnover ratio to 98.93 occurred in 2021. This decline is attributable to a sharp increase in net property and equipment, which rose to 2.16 billion US$. The growth in the asset base during this period exceeded the corresponding growth in revenue, temporarily reducing the efficiency ratio.
Recent Recovery and Stability
By September 30, 2022, the net fixed asset turnover ratio recovered to 111.75. This improvement resulted from continued revenue expansion to 238.6 billion US$ while net property and equipment remained nearly flat at 2.14 billion US$, suggesting that the investments made in 2021 began contributing to higher sales output.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)

AmerisourceBergen Corp., net fixed asset turnover (including operating lease, right-of-use asset) calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Selected Financial Data (US$ in thousands)
Revenue 238,587,006 213,988,843 189,893,926 179,589,121 167,939,635 153,143,826
 
Property and equipment, net 2,135,003 2,162,961 1,484,808 1,770,516 1,892,424 1,797,945
Operating lease right of use assets (included in Other assets) 944,974 1,067,175 443,522 — — —
Property and equipment, net (including operating lease, right-of-use asset) 3,079,977 3,230,136 1,928,330 1,770,516 1,892,424 1,797,945
Long-term Activity Ratio
Net fixed asset turnover (including operating lease, right-of-use asset)1 77.46 66.25 98.48 101.43 88.74 85.18
Benchmarks
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2
Abbott Laboratories 4.25 4.26 — — — —
Elevance Health Inc. 31.64 30.12 — — — —
Intuitive Surgical Inc. 2.53 2.93 — — — —
Medtronic PLC 5.06 4.84 — — — —
UnitedHealth Group Inc. 21.54 21.54 — — — —
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Sector
Health Care Equipment & Services 14.39 13.89 — — — —
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Industry
Health Care 6.90 6.75 — — — —

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

1 2022 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = Revenue ÷ Property and equipment, net (including operating lease, right-of-use asset)
= 238,587,006 ÷ 3,079,977 = 77.46

2 Click competitor name to see calculations.


The financial performance from 2017 to 2022 is characterized by consistent revenue expansion coupled with a significant shift in the company's fixed asset base, which directly impacted the efficiency of asset utilization.

Revenue Growth Trends
A steady and uninterrupted upward trajectory in revenue is observed, increasing from 153,143,826 thousand US dollars in 2017 to 238,587,006 thousand US dollars in 2022. This represents a substantial growth in the top line over the six-year period.
Fixed Asset Investment Patterns
Net property and equipment, including right-of-use assets, remained relatively stable between 2017 and 2020, fluctuating within a narrow range between 1,770,516 and 1,928,330 thousand US dollars. However, a significant increase occurred in 2021, where assets rose to 3,230,136 thousand US dollars, followed by a slight contraction to 3,079,977 thousand US dollars in 2022.
Net Fixed Asset Turnover Analysis
The net fixed asset turnover ratio exhibited a peak in 2019 at 101.43, driven by rising revenues and a simultaneous decrease in net fixed assets. This indicates a period of maximum asset efficiency. A sharp decline is noted in 2021, with the ratio dropping to 66.25; this contraction is attributed to the substantial increase in the fixed asset base which outpaced revenue growth during that fiscal year. By 2022, the ratio showed a recovery to 77.46, resulting from continued revenue growth and a moderate reduction in net fixed assets.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Total Asset Turnover

AmerisourceBergen Corp., total asset turnover calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Selected Financial Data (US$ in thousands)
Revenue 238,587,006 213,988,843 189,893,926 179,589,121 167,939,635 153,143,826
Total assets 56,560,616 57,337,805 44,274,830 39,171,980 37,669,838 35,316,470
Long-term Activity Ratio
Total asset turnover1 4.22 3.73 4.29 4.58 4.46 4.34
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories 0.59 0.57 — — — —
Elevance Health Inc. 1.51 1.41 — — — —
Intuitive Surgical Inc. 0.48 0.42 — — — —
Medtronic PLC 0.35 0.32 — — — —
UnitedHealth Group Inc. 1.31 1.34 — — — —
Total Asset Turnover, Sector
Health Care Equipment & Services 1.06 1.02 — — — —
Total Asset Turnover, Industry
Health Care 0.66 0.62 — — — —

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

1 2022 Calculation
Total asset turnover = Revenue ÷ Total assets
= 238,587,006 ÷ 56,560,616 = 4.22

2 Click competitor name to see calculations.


Revenue exhibited a consistent upward trajectory over the six-year period, increasing from approximately $153.1 billion in 2017 to $238.6 billion by 2022. Simultaneously, total assets expanded from $35.3 billion to $56.6 billion. This simultaneous growth indicates a scaling of operations and a significant increase in the company's resource base to support rising sales volumes.

Asset Efficiency Trends (2017-2019)
An initial upward trend in total asset turnover is observed, with the ratio rising from 4.34 in 2017 to a peak of 4.58 in 2019. This progression indicates that revenue growth outpaced asset accumulation during this interval, reflecting enhanced operational efficiency in utilizing assets to generate sales.
Efficiency Contraction (2020-2021)
A notable decline in asset turnover occurred between 2020 and 2021, reaching a period low of 3.73. The data shows that while revenue grew by approximately 12.7% in 2021, total assets increased by approximately 29.6% in the same period. This disproportionate growth in the asset base led to a temporary reduction in the efficiency of asset utilization.
Recovery and Stabilization (2022)
A recovery in the turnover ratio is observed in 2022, with the value returning to 4.22. This improvement resulted from continued revenue growth coupled with a slight decrease in total assets, suggesting a realignment of the asset base with current revenue-generating requirements.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Equity Turnover

AmerisourceBergen Corp., equity turnover calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Selected Financial Data (US$ in thousands)
Revenue 238,587,006 213,988,843 189,893,926 179,589,121 167,939,635 153,143,826
Total AmerisourceBergen Corporation stockholders’ equity (deficit) (211,559) 223,354 (1,018,924) 2,878,917 2,932,824 2,064,461
Long-term Activity Ratio
Equity turnover1 — 958.07 — 62.38 57.26 74.18
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories 1.19 1.20 — — — —
Elevance Health Inc. 4.29 3.80 — — — —
Intuitive Surgical Inc. 0.56 0.48 — — — —
Medtronic PLC 0.60 0.59 — — — —
UnitedHealth Group Inc. 4.14 3.98 — — — —
Equity Turnover, Sector
Health Care Equipment & Services 2.61 2.42 — — — —
Equity Turnover, Industry
Health Care 1.69 1.67 — — — —

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

1 2022 Calculation
Equity turnover = Revenue ÷ Total AmerisourceBergen Corporation stockholders’ equity (deficit)
= 238,587,006 ÷ -211,559 = —

2 Click competitor name to see calculations.


A consistent upward trajectory in revenue is observed from 2017 to 2022, with values increasing from approximately 153 billion US dollars to 238 billion US dollars. This indicates steady top-line growth over the six-year period. In contrast, the stockholders' equity position exhibits significant volatility and instability, transitioning from a positive balance in the early years to a deficit position in 2020 and 2022.

Revenue Trends
Revenue demonstrated uninterrupted annual growth, expanding from 153,143,826 thousand US dollars in 2017 to 238,587,006 thousand US dollars by 2022. This growth reflects a substantial increase in the scale of operations.
Equity Position and Stability
The equity base shifted from a peak of approximately 2.9 billion US dollars in 2018 and 2019 to a deficit of 1.0 billion US dollars in 2020. Although a slight recovery to 223 million US dollars occurred in 2021, the position reverted to a deficit of 211 million US dollars in 2022. Such fluctuations suggest a highly leveraged capital structure or aggressive capital return strategies.
Equity Turnover Interpretation
The equity turnover ratio shows extreme instability due to the volatility of the equity denominator. While the ratio remained between 57.26 and 74.18 from 2017 to 2019, it became mathematically undefined or skewed in subsequent years. The spike to 958.07 in 2021 is not indicative of an operational efficiency gain, but rather a result of the revenue being measured against a very small positive equity base. The absence of ratios for 2020 and 2022 coincides with periods of negative stockholders' equity, rendering the turnover ratio an unreliable metric for assessing investment efficiency during those intervals.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?